I agree that this site is using cookies. You can find further informations here.
X
Cahill, Daniel
778  results:
Search for persons X
?
1

CTIM-38. NEUROTOXICITY AND MANAGEMENT OF PRIMARY AND SECOND..:

Karschnia, Philipp ; Arrillaga-Romany, Isabel ; Eichler, April...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v71-v71 , 2023
Link: https://doi.org/10.1093/..
 
?
2

DNAR-01. PAR-MEDIATED DNA DAMAGE SIGNALING IN IDH MUTANT GL..:

Kitagawa, Yosuke ; Nasser, Ali ; Chang, Chia...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v98-v98 , 2023
Link: https://doi.org/10.1093/..
 
?
3

SURG-37. ONCOGENIC MUTATIONS AND TUMOR CHARACTERISTICS IN O..:

Prilop, Insa ; Beyer, Friederike ; Herold, Sylvia...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v270-v270 , 2023
Link: https://doi.org/10.1093/..
 
?
4

CTNI-47. DOSE ESCALATION OF ASTX727 IN ADULT PATIENTS WITH ..:

Arrillaga-Romany, Isabel ; Miller, Julie ; Dietrich, Jorg...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v85-v86 , 2023
Link: https://doi.org/10.1093/..
 
?
5

CNSC-22. CANCER NEUROSCIENCE IN THE OR: ELECTROPHYSIOLOGIC ..:

Nelson, Thomas ; Coughlin, Brian ; Cahill, Daniel...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v27-v27 , 2023
Link: https://doi.org/10.1093/..
 
?
6

PATH-51. GENETIC CHARACTERIZATION AND MUTATIONAL PROFILING ..:

Hua, Lingyang ; Fujio, Shingo ; Alkhatib, Majd...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v180-v180 , 2023
Link: https://doi.org/10.1093/..
 
?
7

CTNI-73. ALLIANCE A071601: PHASE II TRIAL OF BRAF/MEK INHIB..:

Brastianos, Priscilla ; Twohy, Erin ; Geyer, Susan...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v94-v94 , 2023
Link: https://doi.org/10.1093/..
 
?
8

EXTH-03. HSP90 INHIBITION OVERCOMES RESISTANCE TO MOLECULAR..:

Tateishi, Kensuke ; Sasame, Jo ; Naoki, Ikegaya...
Neuro-Oncology.  24 (2022)  Supplement_7 - p. vii209-vii209 , 2022
Link: https://doi.org/10.1093/..
 
?
9

The COVID-19 pandemic: How important is face-to-face intera..:

Cahill, Daniel ; Ho, Choy Yeing (Chloe) ; Yang, Joey W.
Global Finance Journal.  54 (2022)  - p. 100674 , 2022
Link: https://doi.org/10.1016/..
 
?
10

PATH-08. A COMPREHENSIVE GENOMIC STUDY OF 390 H3F3A-MUTANT ..:

Williams, Erik ; Brastianos, Priscilla ; Wakimoto, Hiroaki...
Neuro-Oncology.  24 (2022)  Supplement_7 - p. vii151-vii151 , 2022
Link: https://doi.org/10.1093/..
 
?
11

BIOM-65. SAFE MAXIMAL RESECTION OF IDH-WILDTYPE GLIOBLASTOM..:

Shankar, Ganesh ; Massaad, Elie ; Bradley, Joseph...
Neuro-Oncology.  24 (2022)  Supplement_7 - p. vii19-vii19 , 2022
Link: https://doi.org/10.1093/..
 
?
12

EXTH-39. BIOMARKER DRIVEN TARGETING OF RECURRENT IDH MUTANT..:

Nasser, Ali ; Melamed, Lisa ; Nagashima, Hiroaki...
Neuro-Oncology.  24 (2022)  Supplement_7 - p. vii218-vii218 , 2022
Link: https://doi.org/10.1093/..
 
?
13

DNAR-03. TARGETING POLY (ADP-RIBOSE) SIGNALING TO INDUCE LE..:

Kitagawa, Yosuke ; Wakimoto, Hiroaki ; Melamed, Lisa...
Neuro-Oncology.  24 (2022)  Supplement_7 - p. vii90-vii91 , 2022
Link: https://doi.org/10.1093/..
 
?
14

PATH-17. DISTINCT MOLECULAR SUBCLASSES OF H3F3A-WILDTYPE, E..:

Williams, Erik ; Brastianos, Priscilla ; Wakimoto, Hiroaki...
Neuro-Oncology.  24 (2022)  Supplement_7 - p. vii153-vii154 , 2022
Link: https://doi.org/10.1093/..
 
?
15

SURG-11. AKT1 E17K AND NF2 MUTATIONS DOMINATE SPINAL MENING..:

Hua, Lingyang ; Alkhatib, Majd ; Meinhardt, Matthias...
Neuro-Oncology.  24 (2022)  Supplement_7 - p. vii253-vii253 , 2022
Link: https://doi.org/10.1093/..
 
1-15